Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg

The importance of CD8+CD122+ Treg in the maintenance of immune homeostasis has been previously demonstrated in mice. Because the expression pattern of CD8 and CD122 in humans is different from that in mice, human CD8+ Treg that correspond to the murine CD8+CD122+ Treg have not been identified. In this study, we performed DNA microarray analyses to compare the gene expression profiles of CD8+CD122+ cells and CD8+CD122− cells in mice and found that CXCR3 was preferentially expressed in CD8+CD122+ cells. When we analyzed the expression of CD122 and CXCR3 in murine CD8+ cells, we observed a definite population of CD122+CXCR3+ cells. CD8+CXCR3+ cells in mice showed similar regulatory activities to CD8+CD122+ cells by in vivo and in vitro assays. While CD8+CD122+CXCR3+ cells are present in mice, CD8+CXCR3+ cells, but not CD8+CD122+ cells, are present in humans. In the in vitro assay, human CD8+CXCR3+ cells showed the regulatory activity of producing IL‐10 and suppressing IFN‐γ production from CD8+CXCR3− cells. These results suggest that human CD8+CXCR3+ T cells are the counterparts of murine CD8+CD122+ Treg.

[1]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[2]  A. Steck,et al.  The T‐lymphocyte response against myelin‐associated glycoprotein and myelin basic protein in patients with multiple sclerosis , 1993, Neurology.

[3]  H. Griesser,et al.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.

[4]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[5]  M. Leach,et al.  T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice , 1996, The Journal of experimental medicine.

[6]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[7]  E. Shevach.  Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.

[8]  W. Hancock,et al.  Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection , 2000, The Journal of experimental medicine.

[9]  S. Sakaguchi.  Regulatory T cells , 2006, Springer Seminars in Immunopathology.

[10]  T. Malek,et al.  Normal Lymphoid Homeostasis and Lack of Lethal Autoimmunity in Mice Containing Mature T Cells with Severely Impaired IL-2 Receptors1 , 2000, The Journal of Immunology.

[11]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[12]  G. Schuler,et al.  Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood , 2001, The Journal of experimental medicine.

[13]  A. Enk,et al.  Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood , 2001, The Journal of experimental medicine.

[14]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[15]  K. Matsushima,et al.  Neutralization of IFN‐inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis , 2002, European journal of immunology.

[16]  T. Malek,et al.  CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. , 2002, Immunity.

[17]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[18]  Y. Kawamoto,et al.  Essential Roles of CD8+CD122+ Regulatory T Cells in the Maintenance of T Cell Homeostasis , 2004, The Journal of experimental medicine.

[19]  J. Christensen,et al.  Efficient T-Cell Surveillance of the CNS Requires Expression of the CXC Chemokine Receptor 3 , 2004, The Journal of Neuroscience.

[20]  S. Sakaguchi.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[21]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.

[22]  K. Isobe,et al.  Cutting Edge: CD8+CD122+ Regulatory T Cells Produce IL-10 to Suppress IFN-γ Production and Proliferation of CD8+ T Cells1 , 2005, The Journal of Immunology.

[23]  R. Ransohoff,et al.  Chemokine receptor CXCR3: an unexpected enigma. , 2005, Current topics in developmental biology.

[24]  J. V. van Meerwijk,et al.  CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. , 2006, Gastroenterology.

[25]  K. Mills,et al.  Suppression of Antitumor Immunity by IL-10 and TGF-β-Producing T Cells Infiltrating the Growing Tumor: Influence of Tumor Environment on the Induction of CD4+ and CD8+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[26]  Severe Disease, Unaltered Leukocyte Migration, and Reduced IFN-γ Production in CXCR3−/− Mice with Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[27]  U. Panzer,et al.  Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. , 2007, Journal of the American Society of Nephrology : JASN.

[28]  M. Farrar,et al.  IL-2 Receptor β-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells1 , 2007, The Journal of Immunology.

[29]  C. Mottet,et al.  CD4+CD25+Foxp3+ regulatory T cells: from basic research to potential therapeutic use. , 2007, Swiss medical weekly.

[30]  S. Ziegler,et al.  IL‐2Rβ links IL‐2R signaling with Foxp3 expression , 2007 .

[31]  I. Campbell,et al.  CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System1 , 2007, The Journal of Immunology.

[32]  J. Lillard,et al.  CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. , 2007, Endocrine, metabolic & immune disorders drug targets.

[33]  S. Sakaguchi,et al.  Regulatory T cells – a brief history and perspective , 2007, European journal of immunology.

[34]  R. Ransohoff,et al.  Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. , 2008, Blood.

[35]  X. Zheng,et al.  Bystander Central Memory but Not Effector Memory CD8+ T Cells Suppress Allograft Rejection1 , 2008, The Journal of Immunology.

[36]  K. Isobe,et al.  Importance of CD80/CD86–CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells , 2008, Immunology.

[37]  K. Isobe,et al.  Essential Role of CD8+CD122+ Regulatory T Cells in the Recovery from Experimental Autoimmune Encephalomyelitis1 , 2008, The Journal of Immunology.

[38]  K. Isobe,et al.  CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells. , 2008, International immunology.

[39]  D. Saverino,et al.  The frequency of regulatory CD3+CD8+CD28−CD25+ T lymphocytes in human peripheral blood increases with age , 2008, Journal of leukocyte biology.